Heal faster. Protect longer.
The safest nanosilver wound care.
Poseidon™, a nanosilver hydrogel that helps wounds heal faster and safer. With the lowest silver concentration on the market, it kills harmful microbes, disrupts biofilms, and protects healthy tissue — reducing infection risk and speeding recovery.
In clinical studies, Poseidon™ healed faster than leading silver dressings. 96% of patients were infection-free after just 8 days — over 20% better than the market leader (n=100).
At Asclepii, we believe the future of wound care depends on more than innovation—it depends on proven results.
That’s why we partner directly with healthcare providers to run real-world product evaluations of Poseidon™ Nanosilver Hydrogel, ensuring every claim we make is backed by measurable clinical outcomes. Poseidon™ isn’t just another wound dressing—it’s a next-generation hydrogel engineered to maintain the ideal wound healing environment.
Through our 8-week provider-led evaluations, we work alongside clinics to capture data that matters most to clinicians, patients, and payers alike.
1. Collaborative Partnerships
We work hand-in-hand with providers to understand their patient populations and wound care workflows.
2. Real-World Product Evaluations
Over an 8-week period, providers receive free Poseidon™ for up to 10 patients while we track a focused set of outcomes:
- Wound healing progress (percentage area reduction by week 4)
- Pain scores & patient satisfaction
- Clinician satisfaction & usability feedback
- Product versatility across wound types
3. Evidence That Drives Adoption
At the end of each evaluation, providers receive a real-world outcomes report demonstrating Poseidon’s clinical impact, supporting better decision-making and enabling wider adoption.
- Prove clinical value before large-scale adoption
- Build trust with patients and providers through measurable results
- Accelerate access to next-generation wound care solutions
Are you a provider looking to advance wound healing outcomes in your clinic?
Are you a distributor interested in adding Poseidon™ to your portfolio?
Contact Dr. Adam Read, Chief Adoption Officer by entering your contact information below.
Let’s explore how we can partner to evaluate Poseidon™ in your clinic and drive better patient outcomes.
At Asclepii, we believe healthcare innovation should be safer, smarter, and accessible to everyone. Our mission is to rewrite regenerative medicine by harnessing cutting-edge science to create products that heal faster, protect better, and minimize risks for patients and caregivers alike.
Poseidon™ is a new class of hydrogel that features a significant breakthrough in nanotechnology and surface chemistry that has been studied and used widely for over a decade.
An FDA-cleared nanosilver hydrogel that represents 15 years of research, testing, and refinement. With its unique nanotechnology, Poseidon™ helps wounds heal faster and safer than traditional dressings, protecting healthy tissue while reducing infection risk.
But Poseidon™ is just the beginning.
Asclepii is developing a pipeline of advanced wound care and skin health solutions, each built on the same principles of rigorous science, patient safety, and environmental responsibility.
From hospitals and clinics to everyday households, our goal is to bring breakthrough medical technologies out of the lab and into the hands of those who need them most..